Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ni Ding

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Frontiers in Pharmacology|July 17, 2023
Icariin as a potential anticancer agent: a review of its biological effects on various cancersFang-Yuan Liu, Dan-Ni Ding, Yun-Rui Wang, et al.
Journal for Immunotherapy of Cancer|January 5, 2023
Prognostic value of tumor-associated N1/N2 neutrophil plasticity in patients following radical resection of pancreas ductal adenocarcinomaQiangda Chen, Hanlin Yin, Siyao Liu, et al.
Alimentary Pharmacology & Therapeutics|February 10, 2022
Systematic review with meta-analysis: loss of response and requirement of ustekinumab dose escalation in inflammatory bowel diseasesHongsheng Yang, Bingyang Li, Qin Guo, et al.
Epigenomics|February 6, 2024
POU2F2-mediated upregulation of lncRNA <i>PTPRG-AS1</i> inhibits ferroptosis in breast cancer via miR-376c-3p/SLC7A11 axisJun Li, Pei-Ting Li, Wei Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2015
Impact of Specific Epidermal Growth Factor Receptor (EGFR) Mutations and Clinical Characteristics on Outcomes After Treatment With EGFR Tyrosine Kinase Inhibitors Versus Chemotherapy in EGFR-Mutant Lung Cancer: A Meta-AnalysisChee Khoon Lee, Yi-Long Wu, Pei Ni Ding, et al.
Molecular Cancer|June 7, 2024
OLFM4 promotes the progression of intestinal metaplasia through activation of the MYH9/GSK3β/β-catenin pathwayHongfa Wei, Wenchao Li, Leli Zeng, et al.
Theranostics|February 12, 2020
UCH-L1-mediated Down-regulation of Estrogen Receptor α Contributes to Insensitivity to Endocrine Therapy for Breast CancerXi-Sha Chen, Kuan-Song Wang, Wei Guo, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Frontiers in Pharmacology|July 17, 2023
Icariin as a potential anticancer agent: a review of its biological effects on various cancersFang-Yuan Liu, Dan-Ni Ding, Yun-Rui Wang, et al.
Journal for Immunotherapy of Cancer|January 5, 2023
Prognostic value of tumor-associated N1/N2 neutrophil plasticity in patients following radical resection of pancreas ductal adenocarcinomaQiangda Chen, Hanlin Yin, Siyao Liu, et al.
Alimentary Pharmacology & Therapeutics|February 10, 2022
Systematic review with meta-analysis: loss of response and requirement of ustekinumab dose escalation in inflammatory bowel diseasesHongsheng Yang, Bingyang Li, Qin Guo, et al.
Epigenomics|February 6, 2024
POU2F2-mediated upregulation of lncRNA <i>PTPRG-AS1</i> inhibits ferroptosis in breast cancer via miR-376c-3p/SLC7A11 axisJun Li, Pei-Ting Li, Wei Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2015
Impact of Specific Epidermal Growth Factor Receptor (EGFR) Mutations and Clinical Characteristics on Outcomes After Treatment With EGFR Tyrosine Kinase Inhibitors Versus Chemotherapy in EGFR-Mutant Lung Cancer: A Meta-AnalysisChee Khoon Lee, Yi-Long Wu, Pei Ni Ding, et al.
Molecular Cancer|June 7, 2024
OLFM4 promotes the progression of intestinal metaplasia through activation of the MYH9/GSK3β/β-catenin pathwayHongfa Wei, Wenchao Li, Leli Zeng, et al.
Theranostics|February 12, 2020
UCH-L1-mediated Down-regulation of Estrogen Receptor α Contributes to Insensitivity to Endocrine Therapy for Breast CancerXi-Sha Chen, Kuan-Song Wang, Wei Guo, et al.
Pageof 6